Refine
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- ectosomes (1)
- exosomes (1)
- extracellular vesicles (1)
- guidelines (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- reproducibility (1)
- rigor (1)
- standardization (1)
Institute
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points.
Research points to neurofunctional differences underlying fluent speech production in stutterers and non-stutterers. There has been considerably less work focusing on the processes that underlie stuttered speech, primarily due to the difficulty of reliably eliciting stuttering in the unnatural contexts associated with neuroimaging experiments. We used magnetoencephalography (MEG) to test the hypothesis that stuttering events result from global motor inhibition–a “freeze” response typically characterized by increased beta power in nodes of the action-stopping network. We leveraged a novel clinical interview to develop participant-specific stimuli in order to elicit a comparable amount of stuttered and fluent trials. Twenty-nine adult stutterers participated. The paradigm included a cue prior to a go signal, which allowed us to isolate processes associated with stuttered and fluent trials prior to speech initiation. During this pre-speech time window, stuttered trials were associated with greater beta power in the right pre-supplementary motor area, a key node in the action-stopping network, compared to fluent trials. Beta power in the right pre-supplementary area was related to a clinical measure of stuttering severity. We also found that anticipated words identified independently by participants were stuttered more often than those generated by the researchers, which were based on the participants’ reported anticipated sounds. This suggests that global motor inhibition results from stuttering anticipation. This study represents the largest comparison of stuttered and fluent speech to date. The findings provide a foundation for clinical trials that test the efficacy of neuromodulation on stuttering. Moreover, our study demonstrates the feasibility of using our approach for eliciting stuttering during MEG and functional magnetic resonance imaging experiments so that the neurobiological bases of stuttered speech can be further elucidated.